| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/06/2013 | US8501735 N-containing heteroaryl derivatives as JAK3 kinase inhibitors |
| 08/06/2013 | US8501734 Medical intervention in haematological cancers |
| 08/06/2013 | US8501733 Spiroaminodihydrothiazine derivatives |
| 08/06/2013 | US8501732 Aminomethyl quinolone compounds |
| 08/06/2013 | US8501731 Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity |
| 08/06/2013 | US8501729 5-HT3 receptor modulators, methods of making, and use thereof |
| 08/06/2013 | US8501728 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/06/2013 | US8501727 Short acting benzothiazepine calcium channel blockers and uses thereof |
| 08/06/2013 | US8501726 Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 08/06/2013 | US8501724 Purinone compounds as kinase inhibitors |
| 08/06/2013 | US8501723 with stabilizer selected from xylitol, sorbitol, polydextrose, isomalt, dextrose; storage stability |
| 08/06/2013 | US8501722 Methods and compositions for treating bacterial infection |
| 08/06/2013 | US8501721 Postprandial hyperglycemia-improving agent |
| 08/06/2013 | US8501720 Method for treatment of dysmenorrhea |
| 08/06/2013 | US8501719 Androgen treatment in females |
| 08/06/2013 | US8501718 Androgen treatment in females |
| 08/06/2013 | US8501717 Methods to treat and/or prevent mucositis |
| 08/06/2013 | US8501716 C7-fluoro substituted tetracycline compounds |
| 08/06/2013 | US8501715 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/06/2013 | US8501714 Inhibitors of Flaviviridae viruses |
| 08/06/2013 | US8501713 Drug combinations for the treatment of duchenne muscular dystrophy |
| 08/06/2013 | US8501712 Boron-containing small molecules as anti-inflammatory agents |
| 08/06/2013 | US8501711 Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent |
| 08/06/2013 | US8501710 Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents |
| 08/06/2013 | US8501709 Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production |
| 08/06/2013 | US8501708 Adenosine compounds and their use thereof |
| 08/06/2013 | US8501701 Inflammatry bowel disorders, Crohn's disease; antiulcer agents; administering complex of drug and phospholipid |
| 08/06/2013 | US8501700 Method to enhance delivery of glutathione and ATP levels in cells |
| 08/06/2013 | US8501699 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 08/06/2013 | US8501698 Crystal structures of SGLT2 inhibitors and processes for preparing same |
| 08/06/2013 | US8501478 Trehalose click polymers for delivery of biologically active molecules |
| 08/06/2013 | US8501245 Selectively inhibiting estrogen production and providing estrogenic effects in the human body |
| 08/06/2013 | US8501243 Targeting cancer therapy combination |
| 08/06/2013 | US8501242 Methods and compositions for treating neoplasia |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | US8501238 Anti-infective agents and uses thereof |
| 08/06/2013 | US8501234 Reverse vesicle |
| 08/06/2013 | US8501228 Stable compositions of famotidine and ibuprofen |
| 08/06/2013 | US8501227 Stable pharmaceutical compositions without a stabilizer |
| 08/06/2013 | US8501226 Coating method |
| 08/06/2013 | US8501225 Stable pharmaceutical composition and methods of using same |
| 08/06/2013 | US8501212 Immobilised biological entities |
| 08/06/2013 | US8501210 Gel composition and pack cosmetic using the same |
| 08/06/2013 | US8501209 Gel-type water absorbent |
| 08/06/2013 | US8501200 Ophthalmic compositions with biguanide and PEG-glycerol esters |
| 08/06/2013 | US8501199 Synthetic blocking reagents |
| 08/06/2013 | US8501186 Adjuvant composition for vaccine |
| 08/06/2013 | US8501183 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 08/06/2013 | US8501167 Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer |
| 08/06/2013 | US8501166 Pyrimidinyl indole compounds |
| 08/06/2013 | US8501165 Biocompatible tissue-bonding adhesive composition comprising an isocyanate-capped polyether, especially a ethylene oxide-propylene oxide polymer |
| 08/06/2013 | US8501164 Nicotine lozenge compositions |
| 08/06/2013 | US8501163 Protection against sunburn and skin problems with topical and orally-ingested dosages of zeaxanthin |
| 08/06/2013 | US8501158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
| 08/06/2013 | US8501110 uniform heating and cooling of the containers, preventing stress cracks; gentle; use of radiant heat-generating heating units that act on the container bottoms in concert with the hot air from the ventilating fan units |
| 08/06/2013 | CA2771928C Oxazine derivatives and their use in the treatment of neurological disorders |
| 08/06/2013 | CA2758251C Serotonin and norepinephrine reuptake inhibitor |
| 08/06/2013 | CA2752421C Amino ester derivatives, salts thereof and methods of use |
| 08/06/2013 | CA2751901C Mineralocorticoid receptor antagonist and methods of use |
| 08/06/2013 | CA2732620C Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 08/06/2013 | CA2723119C Pharmaceutical compound comprising a strontium salt, vitamin d and a cyclodextrin |
| 08/06/2013 | CA2714081C Methods and compositions for treating conditions of the eye |
| 08/06/2013 | CA2709119C Preventive or therapeutic agent for inflammatory bowel diseases |
| 08/06/2013 | CA2703000C Water-immiscible materials as vehicles for drug delivery |
| 08/06/2013 | CA2690686C Amine compound and pharmaceutical use thereof |
| 08/06/2013 | CA2674347C Solid state forms of racemic ilaprazole |
| 08/06/2013 | CA2666603C Therapeutic pyrazolyl thienopyridines and uses thereof for treating tgf.beta. mediated conditions |
| 08/06/2013 | CA2662587C Quinazoline based egfr inhibitors |
| 08/06/2013 | CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 08/06/2013 | CA2652074C Substituted carboxamides as group 1 metabotropic receptor antagonists |
| 08/06/2013 | CA2647123C Mucosal bioadhesive slow release carrier for delivering active principles |
| 08/06/2013 | CA2646624C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/06/2013 | CA2630624C Compositions and methods for increasing insulin sensitivity |
| 08/06/2013 | CA2629321C Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/06/2013 | CA2629223C Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/06/2013 | CA2629065C 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 08/06/2013 | CA2625741C Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde |
| 08/06/2013 | CA2614988C Breath freshening and oral cleansing product comprising a magnolia bark extract and surfactant |
| 08/06/2013 | CA2609388C Novel piperidine derivative |
| 08/06/2013 | CA2608073C Imidazolone phenylalanine derivatives |
| 08/06/2013 | CA2599124C Imidazo (1,2-a) pyridine compounds as vegf-r2 inhibitors |
| 08/06/2013 | CA2598759C Trofosfamide containing film-coated tablets and procedure for its production |
| 08/06/2013 | CA2588513C 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/06/2013 | CA2586345C Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran |
| 08/06/2013 | CA2586271C Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 08/06/2013 | CA2584971C Methods for inhibition of nkt cells |
| 08/06/2013 | CA2584465C Heterocyclic carbonyl compounds and their use as sgk-inhibitors |
| 08/06/2013 | CA2584338C Gabapentin prodrug sustained release oral dosage forms |
| 08/06/2013 | CA2575223C Azaindole inhibitors of mtp and apob |
| 08/06/2013 | CA2570499C Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
| 08/06/2013 | CA2570199C Use of highly-sulfated polysaccharide derivatives with low molecular weight to modulate angiogenesis |
| 08/06/2013 | CA2568501C Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
| 08/06/2013 | CA2567513C Histamine h3 receptor agents, preparation and therapeutic uses |
| 08/06/2013 | CA2564784C Episomal fusion gene |
| 08/06/2013 | CA2563180C Non-nucleoside reverse transcriptase inhibitors |
| 08/06/2013 | CA2560741C Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 08/06/2013 | CA2560653C Angiogenesis inhibitors and uses thereof |
| 08/06/2013 | CA2557942C 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |
| 08/06/2013 | CA2557304C Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
| 08/06/2013 | CA2556450C Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |